A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer
Article in Pharmaceutics (April 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Pharmaceutics (April 2024)
Article in Scientific Reports (February 2024)
Book chapter (January 2024)